-
Green Market Report
Aug 19, 2024, 10:56 am218 ptsTopMindBio Therapeutics Corp. (CSE:MBIO) reported durability data from its Phase 2A clinical trials in depressed patients testing MB22001, MindBio’s proprietary self-administered take-home microdose of Lysergic Acid Diethylamide (LSD). MindBio announced that the Phase 2a clinical trial demonstrated excellent…
Trending Today on NewsBudz
NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.
Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.